🇺🇸 FDA
Patent

US 8242164

3-(phenoxyphenylmethyl)pyrrolidine compounds

granted A61KA61K31/40A61P

Quick answer

US patent 8242164 (3-(phenoxyphenylmethyl)pyrrolidine compounds) held by Theravance, Inc. expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/40, A61P, A61P13/10, A61P15/12